Rachel Haurwitz
Founder bei CARIBOU BIOSCIENCES, INC.
Vermögen: 18 Mio $ am 31.03.2024
Profil
Rachel E.
Haurwitz is the founder and has held multiple positions throughout her career.
She founded Caribou Biosciences, Inc. in 2011, where she currently serves as the President, Chief Executive Officer & Director.
In 2014, she also founded Intellia Therapeutics, Inc. and served as a Director until 2016.
In addition to her founding positions, Dr. Haurwitz currently holds several jobs.
Since 2020, she has been a Director at the Biotechnology Innovation Organization.
Since 2019, she has also been a Director at BIOCOM.
Furthermore, in 2021, she became an Independent Director at Seer, Inc. (California).
Dr. Haurwitz's education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.02.2024 | 3 508 095 ( 3,88% ) | 18 Mio $ | 31.03.2024 | |
SEER, INC. CLASS A
0,05% | 14.06.2023 | 29 437 ( 0,05% ) | 55 930 $ | 31.03.2024 |
Aktive Positionen von Rachel Haurwitz
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Founder | 28.10.2011 |
| SEER, INC. | Director/Board Member | 08.11.2021 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 26.02.2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01.02.2020 |
Ehemalige bekannte Positionen von Rachel Haurwitz
| Unternehmen | Position | Ende |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Founder | 01.11.2016 |
Ausbildung von Rachel Haurwitz
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| SEER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
